Industry News
Poorly controlled celiac disease could up lymphoma risk
Aug 06, 2013
People who have poorly controlled celiac disease may have a higher risk of developing lymphoma, according to a study published in the journal Annals of Internal Medicine. Researchers from Sweden carried out a population-based cohort study of 7,625 patients with celiac disease (CD) between 2006 and 2008... Read More
Celiacs may be at higher lymphoma risk
Aug 06, 2013
People who have poorly controlled celiac disease may have a higher risk of developing lymphoma, according to a study published in the journal Annals of Internal Medicine. Researchers from Sweden carried out a population-based cohort study of 7,625 patients with celiac disease (CD) between 2006 and 2008... Read More
Scientists find long-sought method to efficiently make ingenol a complex anticancer compound
Aug 06, 2013
Scientists at The Scripps Research Institute (TSRI) have achieved the first efficient chemical synthesis of ingenol, a highly complex, plant-derived compound that has long been of interest to drug developers for its anticancer potential. The achievement will enable scientists to synthesize a wide variety of ingenol derivatives and investigate their therapeutic properties... Read More
Scientists discover a molecular 'switch' in cancers of the testis and ovary - LIN28
Aug 06, 2013
Cambridge scientists have identified an 'on/off' switch in a type of cancer which typically occurs in the testes and ovaries called 'malignant germ cell tumours'. The research was published on 1st August, in the journal Cancer Research. Malignant germ cell tumours arise in sperm- or egg-forming cells and usually occur in the reproductive organs, the testes or ovaries... Read More
Mailed outreach invitations to underserved patients for colorectal cancer screening appear to result in higher screening rate than usual care
Aug 05, 2013
Among underserved patients whose colorectal cancer (CRC) screening was not up to date, mailed outreach invitations appear to result in higher CRC screening compared with usual care, according to a study by Samir Gupta, M.D., M.S.C.S., of the Veterans Affairs San Diego Healthcare System, and the University of California, San Diego, and colleagues... Read More
Long-term calcium-channel blocker use for hypertension associated with higher breast cancer risk
Aug 05, 2013
Long-term use of a calcium-channel blocker to treat hypertension (high blood pressure) is associated with higher breast cancer risk, according to a report published by JAMA Internal Medicine, a JAMA Network publication... Read More
New drivers of glioblastoma
Aug 05, 2013
Several genetic drivers of glioblastomas - malignant brain tumors - are reported in an article published online this week in Nature Genetics. These discoveries shed light on how these tumors develop and suggest possible treatment options for a subset of glioblastoma patients. Glioblastoma is difficult to treat and usually associated with poor clinical outcomes... Read More
Tumor cell vaccination trial to promote anti-leukemia responses
Aug 05, 2013
Chronic lymphocytic leukemia (CLL) is a cancer of the blood and bone marrow that most often affects older adults. CLL responds to bone marrow stem cell transplantation (allo-HSCT); however, the rate of relapse for CLL remains relatively high... Read More
New treatment strategy for breast cancer spread to brain
Aug 05, 2013
Researchers at UCLA's Jonsson Comprehensive Cancer Center (JCCC) have successfully combined cellular therapy and gene therapy in a mouse model system to develop a viable treatment strategy for breast cancer that has metastasized, or spread, to the patient's brain. The laboratory study was led by Carol Kruse, professor of neurosurgery and member of JCCC and the UCLA Brain Research Institute... Read More
Depletion of FoxM1 in prostate epithelial cells inhibits tumor cell proliferation - possible new approach to prostate cancer treatment
Aug 05, 2013
A study in the Journal of Biological Chemistry identifies a new therapeutic approach to treat prostate cancer. Conducted at Cincinnati Children's Hospital Medical Center, the research shows that expression of the FoxM1 protein is essential for prostate cancer to develop in mouse models. The study appears in the journal's Aug. 2 edition... Read More
Previous Page Next Page